Connecting to SEC EDGAR… PricingSign in
← All filings

DCOY

Decoy Therapeutics Inc. SEC filings
Pharmaceutical Preparations · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for DCOY right now.
Filing history
2026-10-16
EFFECT EFFECT
Filing ↗
2026-10-16
Prospectus 424B3
Filing ↗
2026-10-07
Registration (share sale/IPO) S-1
Filing ↗
2026-09-23
Current report 8-K
Material agreementShare sale (dilution)Reg FD disclosure
Filing ↗
2026-09-15
Current report 8-K
Shareholder vote
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-08-14
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-12
Quarterly report 10-Q
Filing ↗
2026-08-04
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-08-04
Proxy material DEFA14A
Filing ↗
2026-07-31
New insider's holdings 3
Filing ↗
2026-07-24
PRE 14A PRE 14A
Filing ↗
2026-07-17
EFFECT EFFECT
Filing ↗
2026-07-17
Prospectus 424B3
Filing ↗
2026-07-15
Current report 8-K
Shareholder vote
Filing ↗
2026-07-10
Registration (share sale/IPO) S-1
Filing ↗
2026-06-29
Current report 8-K
Material agreementShare sale (dilution)Reg FD disclosure
Filing ↗
2026-06-24
EFFECT EFFECT
Filing ↗
2026-06-15
Registration (share sale/IPO) S-1
Filing ↗
2026-06-05
RW RW
Filing ↗
2026-06-04
Proxy material DEFA14A
Filing ↗
2026-06-04
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-05-19
Current report 8-K
Item 5.08Other event
Filing ↗
2026-05-08
Quarterly report 10-Q
Filing ↗
2026-04-30
Annual report (amended) 10-K/A
Filing ↗
2026-04-02
Employee stock plan shares S-8
Filing ↗
2026-04-02
Current report 8-K
Other event
Filing ↗
2026-03-31
Annual report 10-K
Filing ↗
2026-03-05
Current report 8-K
Shareholder rights changeBylaws changeOther event
Filing ↗
2026-02-25
Current report 8-K
Shareholder vote
Filing ↗
2026-02-17
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗